TipRanks
Theralase Technologies (DE:TTX)
FRANKFURT:TTX
Germany Market
TTX
Theralase Technologies
RESEARCH TOOLSreports

Theralase Technologies (TTX) Income Statement

1 Followers

Theralase Technologies Income Statement

Last quarter (Q2 2026), Theralase Technologies's total revenue was C$164.29K, a decrease of -25.23% from the same quarter last year. In Q2, Theralase Technologies's net income was C$-1.06M. See Theralase Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Dec 24Dec 23Mar 23Mar 22
Total Revenue
C$ 816.47KC$ 1.03MC$ 1.07MC$ 1.14MC$ 780.64K
Gross Profit
C$ 241.51KC$ 554.03KC$ 562.13KC$ 628.17KC$ 309.94K
Operating Expenses
C$ 4.68MC$ 4.84MC$ 5.15MC$ 5.86MC$ 4.85M
Depreciation and Amortization
C$ 265.62KC$ 272.09KC$ 286.12KC$ 313.23KC$ 276.15K
EBITDA
C$ -3.91MC$ -3.96MC$ -4.25MC$ -4.90MC$ -4.31M
Operating Income
C$ -4.18MC$ -4.29MC$ -4.59MC$ -5.20MC$ -4.52M
Other Income/Expenses
C$ 54.52KC$ 32.23KC$ 23.39KC$ -3.76KC$ 130.48K
Pretax Income
C$ -4.12MC$ -4.26MC$ -4.57MC$ -5.24MC$ -4.41M
Net Income
C$ -4.12MC$ -4.26MC$ -4.57MC$ -5.25MC$ -4.42M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.03C$ -0.02
Diluted EPS
C$ -0.02C$ -0.02C$ -0.02C$ -0.03C$ -0.02
Weighted Average Shares Outstanding
 253.13M 240.07M 219.97M 207.92M 204.28M
Weighted Average Shares Outstanding (Diluted)
 253.13M 240.07M 219.97M 207.92M 204.28M
Currency in CAD

Theralase Technologies Earnings and Revenue History